[Editorial] Accelerating research for Parkinson`s disease (Lancet Neurology)

Despite considerable ongoing translational and clinical research efforts, no disease-modifying drugs have been approved for Parkinson`s disease. The Accelerating Medicines Partnership Parkinson`s disease (AMP PD) programme, launched on Jan 30, 2018, is the most ambitious initiative so far to find a cure for Parkinson`s disease. Formed by the US National Institutes of Health (NIH), the US Food and Drug Administration (FDA), five biopharmaceutical and life science companies, and one non-profit organisation, this partnership is focused on discovering novel therapeutic targets and on developing biomarkers to help validate existing therapeutic targets for Parkinson`s disease.